Your browser is no longer supported. Please, upgrade your browser.
Settings
PHR [NYSE]
Phreesia, Inc.
Index- P/E- EPS (ttm)-0.61 Insider Own3.20% Shs Outstand44.16M Perf Week10.03%
Market Cap2.77B Forward P/E- EPS next Y-0.27 Insider Trans-20.64% Shs Float41.99M Perf Month12.35%
Income-22.90M PEG- EPS next Q-0.10 Inst Own87.80% Short Float3.14% Perf Quarter85.29%
Sales139.70M P/S19.80 EPS this Y-250.10% Inst Trans0.97% Short Ratio2.63 Perf Half Y115.84%
Book/sh7.00 P/B8.99 EPS next Y25.70% ROA-11.20% Target Price60.54 Perf Year128.20%
Cash/sh5.78 P/C10.89 EPS next 5Y- ROE-16.10% 52W Range16.01 - 64.17 Perf YTD16.03%
Dividend- P/FCF- EPS past 5Y- ROI-11.60% 52W High-1.89% Beta-
Dividend %- Quick Ratio7.20 Sales past 5Y- Gross Margin65.10% 52W Low293.25% ATR2.87
Employees532 Current Ratio7.20 Sales Q/Q17.40% Oper. Margin-15.80% RSI (14)72.11 Volatility4.47% 4.59%
OptionableYes Debt/Eq0.11 EPS Q/Q-156.00% Profit Margin-16.40% Rel Volume1.00 Prev Close63.73
ShortableYes LT Debt/Eq0.09 EarningsDec 08 AMC Payout- Avg Volume501.27K Price62.96
Recom1.80 SMA2011.09% SMA5027.02% SMA20084.87% Volume499,313 Change-1.21%
Nov-11-20Initiated Stephens Overweight $50
Oct-27-20Initiated Needham Buy $44
Sep-22-20Initiated DA Davidson Buy $35
Jul-14-20Initiated Citigroup Neutral
May-15-20Initiated Guggenheim Buy $31
Apr-21-20Initiated RBC Capital Mkts Sector Perform $21
Apr-13-20Initiated SVB Leerink Outperform
Jan-31-20Initiated KeyBanc Capital Markets Overweight $36
Jan-09-20Initiated Cantor Fitzgerald Overweight $32
Dec-20-19Initiated Raymond James Outperform $33
Oct-11-19Initiated Robert W. Baird Outperform $31
Aug-13-19Initiated JP Morgan Overweight $33
Aug-12-19Initiated William Blair Outperform
Aug-12-19Initiated Wells Fargo Outperform
Aug-12-19Initiated Piper Jaffray Overweight $33
Jul-23-19Initiated Chardan Capital Markets Buy $33
Dec-21-20 08:00AM  
Dec-19-20 04:17PM  
Dec-10-20 08:00AM  
Dec-09-20 03:30PM  
06:30AM  
Dec-08-20 05:25PM  
04:37PM  
04:22PM  
04:11PM  
Dec-01-20 12:30PM  
Nov-13-20 10:20AM  
Nov-10-20 12:00PM  
11:01AM  
Oct-27-20 10:35AM  
Oct-26-20 08:00AM  
Oct-23-20 04:10PM  
Oct-21-20 12:59PM  
07:30AM  
Oct-19-20 04:15PM  
Oct-12-20 12:14PM  
Oct-09-20 01:51PM  
12:11PM  
Oct-01-20 08:00AM  
Sep-09-20 04:00PM  
06:30AM  
Sep-08-20 05:05PM  
04:09PM  
Sep-01-20 12:30PM  
Aug-24-20 07:45AM  
Aug-14-20 09:00AM  
Aug-13-20 09:00AM  
Aug-12-20 12:28PM  
12:23PM  
Jul-28-20 09:00AM  
Jul-16-20 08:00AM  
Jun-22-20 02:43PM  
Jun-16-20 08:00AM  
Jun-11-20 09:51AM  
Jun-09-20 06:30AM  
Jun-08-20 04:09PM  
May-22-20 08:00AM  
Apr-24-20 10:30AM  
09:26AM  
Apr-23-20 06:30AM  
Apr-22-20 04:09PM  
Apr-20-20 12:58PM  
Mar-25-20 09:00AM  
Feb-27-20 10:41AM  
Jan-31-20 03:07PM  
10:01AM  
Dec-31-19 06:21AM  
Dec-19-19 10:36PM  
Dec-17-19 11:15AM  
Dec-12-19 09:26PM  
Dec-11-19 06:59AM  
Dec-10-19 05:42PM  
04:49PM  
Dec-09-19 04:10PM  
Nov-21-19 10:15AM  
Nov-07-19 08:00AM  
Oct-30-19 08:00AM  
Oct-17-19 09:29AM  
Sep-11-19 01:10PM  
Sep-10-19 08:00AM  
06:30AM  
Sep-09-19 05:45PM  
Aug-19-19 08:56AM  
Aug-14-19 08:18AM  
Jul-22-19 04:05PM  
Jul-18-19 05:49PM  
02:40PM  
12:30PM  
Jul-17-19 11:06PM  
Jul-15-19 10:10AM  
Jul-08-19 06:43PM  
10:45AM  
Jun-24-19 08:00AM  
May-23-19 07:18AM  
Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company's Phreesia Platform offers a suite of solutions to manage the patient intake process, as well as an integrated payments solution for processing of patient payments. It deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a Web-based dashboard for providers; PhreesiaPads, which are self-service intake tablets; and Arrivals Stations that are on-site kiosks. The company's Phreesia Platform also provides a registration solution to automate patient self-registration; patient activation solution that enables providers to communicate with their patients through surveys, announcements, messaging, and health campaigns; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, and cost estimation tools; clinical support solution that collects clinical intake and PRO data for approximately 25 specialties; appointments solution for online appointments, reminders, and referral tracking; and life sciences solution to deliver targeted and clinically relevant marketing content to patients. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and life sciences, pharmaceutical, medical device, and biotechnology companies. Phreesia, Inc. has a strategic alliance agreement with Allscripts Healthcare, LLC. The company was founded in 2005 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Roberts EvanChief Operating OfficerJan 05Sale53.4321,4681,146,967585,387Jan 06 08:39 PM
VanDuyn Amy BethSVP, Human ResourcesJan 04Option Exercise0.8450042044,767Jan 06 08:32 PM
Smith Mark DouglasDirectorJan 04Option Exercise4.716,00028,26012,110Jan 06 08:34 PM
VanDuyn Amy BethSVP, Human ResourcesJan 04Sale54.2650027,12844,267Jan 06 08:32 PM
Roberts EvanChief Operating OfficerJan 04Sale52.4880,2454,211,615606,280Jan 06 08:39 PM
Smith Mark DouglasDirectorJan 04Sale52.576,000315,4116,110Jan 06 08:34 PM
CAHILL EDWARD LDirectorDec 24Sale57.2224,3701,394,48170,709Dec 28 05:12 PM
Pegus CherylDirectorDec 17Sale56.158,415472,49216,775Dec 18 05:14 PM
Pegus CherylDirectorDec 16Option Exercise11.8920,764246,88447,922Dec 18 05:14 PM
Pegus CherylDirectorDec 16Sale55.8322,7321,269,08925,190Dec 18 05:14 PM
Altier ThomasChief Financial OfficerOct 23Option Exercise0.848,6697,282169,160Oct 26 05:55 PM
Altier ThomasChief Financial OfficerOct 23Sale38.218,669331,207160,491Oct 26 05:55 PM
Altier ThomasChief Financial OfficerOct 22Option Exercise0.8486,23772,439246,728Oct 26 05:55 PM
Altier ThomasChief Financial OfficerOct 22Sale37.6586,2373,246,547160,491Oct 26 05:55 PM
Altier ThomasChief Financial OfficerOct 12Option Exercise0.006,7790167,270Oct 14 07:24 PM
Altier ThomasChief Financial OfficerOct 12Sale32.136,779217,779160,491Oct 14 07:24 PM
Linetsky DavidSVP, Life SciencesOct 01Option Exercise4.711,3776,486132,554Oct 05 06:49 PM
Roberts EvanChief Operating OfficerOct 01Sale30.9314,774456,952686,525Oct 05 06:48 PM
Linetsky DavidSVP, Life SciencesOct 01Sale30.974,477138,667128,077Oct 05 06:49 PM
Altier ThomasChief Financial OfficerSep 11Option Exercise0.846,7795,694121,760Sep 15 06:33 PM
Altier ThomasChief Financial OfficerSep 11Sale27.996,779189,712114,981Sep 15 06:33 PM
Kallenbach CharlesGeneral Counsel & SecretaryAug 17Option Exercise2.552,5006,37541,650Aug 20 07:32 PM
Kallenbach CharlesGeneral Counsel & SecretaryAug 17Sale29.842,50074,59339,150Aug 20 07:32 PM
Altier ThomasChief Financial OfficerAug 11Option Exercise0.846,7795,694121,760Aug 12 05:59 PM
Altier ThomasChief Financial OfficerAug 11Sale30.106,779204,035114,981Aug 12 05:59 PM
Smith Mark DouglasDirectorAug 10Option Exercise4.716,00028,26012,110Aug 12 06:01 PM
Smith Mark DouglasDirectorAug 10Sale30.306,000181,8256,110Aug 12 06:01 PM
Nathan DanielChief Technology OfficerJul 31Option Exercise0.697,0004,83065,196Aug 04 06:22 PM
Nathan DanielChief Technology OfficerJul 31Sale30.038,804264,39156,392Aug 04 06:22 PM
CAHILL EDWARD LDirectorJul 21Sale29.029,080263,52046,467Jul 22 06:35 PM
Kallenbach CharlesGeneral Counsel & SecretaryJul 17Option Exercise2.552,5006,37541,650Jul 21 06:49 PM
Nathan DanielChief Technology OfficerJul 17Option Exercise0.8438,68332,49446,646Jul 21 06:49 PM
Kallenbach CharlesGeneral Counsel & SecretaryJul 17Sale29.292,50073,23439,150Jul 21 06:49 PM
Nathan DanielChief Technology OfficerJul 17Sale29.2538,6831,131,4317,963Jul 21 06:49 PM
Linetsky DavidSVP, Life SciencesJul 01Option Exercise4.711,3766,481135,652Jul 06 06:01 PM
Roberts EvanChief Operating OfficerJul 01Sale28.4512,500355,623701,299Jul 06 06:07 PM
Linetsky DavidSVP, Life SciencesJul 01Sale28.244,475126,396131,177Jul 06 06:01 PM
Kallenbach CharlesGeneral Counsel & SecretaryJun 17Option Exercise2.552,5006,37541,650Jun 19 05:06 PM
Kallenbach CharlesGeneral Counsel & SecretaryJun 17Sale29.262,50073,14539,150Jun 19 05:06 PM
Munson GillianDirectorJun 12Sale28.325,000141,60016,048Jun 16 06:15 PM
Davidoff Michael J.See RemarksJun 11Option Exercise0.8413,08410,991124,087Jun 15 06:07 PM
Kallenbach CharlesGeneral Counsel & SecretaryMay 18Option Exercise2.552,5006,37541,650May 20 07:43 PM
Kallenbach CharlesGeneral Counsel & SecretaryMay 18Sale27.202,50068,00039,150May 20 07:43 PM
Linetsky DavidSVP, Life SciencesMay 07Sale26.002556,630134,276May 11 04:43 PM
VanDuyn Amy BethSVP, Human ResourcesMay 01Option Exercise2.0313,47427,35257,741May 04 08:37 PM
Altier ThomasChief Financial OfficerMay 01Sale24.341,09626,674114,981May 04 08:43 PM
VanDuyn Amy BethSVP, Human ResourcesMay 01Sale24.8813,474335,18644,267May 04 08:37 PM
Linetsky DavidSVP, Life SciencesApr 27Option Exercise4.711,3766,481137,731Apr 29 04:44 PM
Linetsky DavidSVP, Life SciencesApr 27Sale26.004,220109,720133,511Apr 29 04:44 PM
Kallenbach CharlesGeneral Counsel & SecretaryApr 23Option Exercise2.555,00012,75043,461Apr 27 04:48 PM
Kallenbach CharlesGeneral Counsel & SecretaryApr 23Sale25.005,000125,00038,461Apr 27 04:48 PM
Davidoff Michael J.See RemarksApr 09Sale20.104,28586,141105,314Apr 13 05:24 PM
Davidoff Michael J.See RemarksApr 01Sale20.131,40428,264109,599Apr 03 05:05 PM
Davidoff Michael J.See RemarksMar 30Sale20.0068913,780111,003Apr 01 05:35 PM
Davidoff Michael J.See RemarksMar 27Option Exercise0.7931,85625,052111,692Mar 30 04:49 PM
Davidoff Michael J.See RemarksMar 26Sale20.063,85177,26279,836Mar 30 04:49 PM
Davidoff Michael J.See RemarksMar 23Sale20.0670014,04583,687Mar 25 05:19 PM
Linetsky DavidSVP, Life SciencesMar 13Option Exercise0.8350,06041,322136,355Mar 17 05:04 PM
VanDuyn Amy BethSVP, Human ResourcesMar 13Option Exercise0.696,8264,71043,086Mar 17 05:02 PM
Roberts EvanChief Operating OfficerMar 13Option Exercise0.8425,00021,000712,788Mar 17 05:00 PM
Indig ChaimChief Executive OfficerMar 12Option Exercise0.84100,00084,0001,098,180Mar 16 04:40 PM
Roberts EvanChief Operating OfficerMar 09Option Exercise0.8450,00042,000687,788Mar 10 05:23 PM
Davidoff Michael J.See RemarksMar 02Option Exercise4.7117,06680,381101,453Mar 04 05:07 PM
Davidoff Michael J.See RemarksMar 02Sale29.8517,066509,35184,387Mar 04 05:07 PM
Kallenbach CharlesGeneral Counsel & SecretaryFeb 19Option Exercise2.555012838,511Feb 21 04:26 PM
Nathan DanielChief Technology OfficerFeb 19Sale33.709,142308,10756,920Feb 21 04:26 PM
Kallenbach CharlesGeneral Counsel & SecretaryFeb 19Sale32.85501,64338,461Feb 21 04:26 PM
Kallenbach CharlesGeneral Counsel & SecretaryFeb 18Option Exercise2.552,4506,24840,911Feb 20 04:50 PM
Nathan DanielChief Technology OfficerFeb 18Option Exercise0.736,8264,98375,123Feb 20 04:59 PM
Nathan DanielChief Technology OfficerFeb 18Sale32.829,061297,39866,062Feb 20 04:59 PM
Linetsky DavidSVP, Life SciencesFeb 18Sale32.853,188104,71886,295Feb 20 04:49 PM
Kallenbach CharlesGeneral Counsel & SecretaryFeb 18Sale32.822,45080,41338,461Feb 20 04:50 PM
Altier ThomasChief Financial OfficerFeb 14Option Exercise0.0045,5100160,491Sep 23 07:43 PM
Weintraub MichaelDirectorFeb 12Option Exercise2.0310,68021,680169,054Feb 14 05:19 PM
Weintraub MichaelDirectorFeb 12Sale32.5110,680347,198158,374Feb 14 05:19 PM
Weintraub MichaelDirectorFeb 11Option Exercise2.039,14318,560167,517Feb 12 08:32 PM
Weintraub MichaelDirectorFeb 11Sale33.029,143301,925158,374Feb 12 08:32 PM
VanDuyn Amy BethSVP, Human ResourcesFeb 10Option Exercise0.736,8264,98343,086Feb 12 08:31 PM
Weintraub MichaelDirectorFeb 10Option Exercise2.0315,17730,809173,551Feb 12 08:32 PM
Altier ThomasChief Financial OfficerFeb 10Option Exercise2.03266540125,936Feb 12 08:30 PM
Weintraub MichaelDirectorFeb 10Sale32.7915,177497,620158,374Feb 12 08:32 PM
VanDuyn Amy BethSVP, Human ResourcesFeb 10Sale32.846,826224,17536,260Feb 12 08:31 PM
Altier ThomasChief Financial OfficerFeb 10Sale32.8510,955359,873114,981Feb 12 08:30 PM
Indig ChaimChief Executive OfficerFeb 06Option Exercise2.0380,000162,4001,078,180Feb 10 06:14 PM
Indig ChaimChief Executive OfficerFeb 06Sale33.1180,0002,648,928998,180Feb 10 06:14 PM
Davidoff Michael J.See RemarksFeb 06Sale33.104,550150,58584,387Feb 10 06:15 PM
Indig ChaimChief Executive OfficerFeb 04Option Exercise2.0344,04789,4151,058,917Feb 05 05:14 PM
Indig ChaimChief Executive OfficerFeb 04Sale31.4460,7371,909,681998,180Feb 05 05:14 PM
Davidoff Michael J.See RemarksFeb 03Option Exercise2.0311,37723,095100,314Feb 05 04:58 PM
Indig ChaimChief Executive OfficerFeb 03Option Exercise2.0355,953113,5851,070,823Feb 05 05:14 PM
Indig ChaimChief Executive OfficerFeb 03Sale30.8155,9531,724,0021,014,870Feb 05 05:14 PM
Davidoff Michael J.See RemarksFeb 03Sale30.9011,377351,60388,937Feb 05 04:58 PM
Roberts EvanChief Operating OfficerJan 27Sale29.1769,4482,026,132632,343Jan 28 05:44 PM